Medicine guide

TYRUKO

As listed in the register: TYRUKO 300 mg, solution à diluer pour perfusion

20 mg · solution à diluer pour perfusion

  • Prescription only
Active substance
Natalizumab
Made by
SANDOZ (AUTRICHE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made bySANDOZ (AUTRICHE)
Active substanceNatalizumab
Strength20 mg
Formsolution à diluer pour perfusion
Routeintraveineuse
Dispensing (as stated by the register)réservé à l'usage HOSPITALIER · prescription réservée aux spécialistes et services NEUROLOGIE · liste I
MarketedYes, according to the register
Reinforced monitoringYes — under reinforced monitoring, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/23/1745
Name in the registerTYRUKO 300 mg, solution à diluer pour perfusion
Packs1 flacon en verre de 15 mL
CIS60779570
CIP133400955097273

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.